Tolerance, Pharmacokinetics / Pharmacodynamics (PK / PD) and Immunogenicity of Pegylated Uric Acid Oxidase for Injection in Healthy Adults and Hyperuricemia Volunteers

NCT05226013 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Hyperuricemia

Interventions

DRUG: Polyglycol lated urate oxidase for injection
DRUG: Placebo

Sponsor

The Affiliated Hospital of Qingdao University